BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34007904)

  • 1. The changing face of Australian data reforms: impact on pharmacoepidemiology research.
    de Oliveira Costa J; Bruno C; Schaffer AL; Raichand S; Karanges EA; Pearson SA
    Int J Popul Data Sci; 2021 Apr; 6(1):1418. PubMed ID: 34007904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013).
    Pearson SA; Pesa N; Langton JM; Drew A; Faedo M; Robertson J
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):447-55. PubMed ID: 25833702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national study on prescribed medicine use in Australia on a typical day.
    Wylie CE; Daniels B; Brett J; Pearson SA; Buckley NA
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1046-1053. PubMed ID: 32779806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
    Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dispensing patterns of emergency medicines prescribed by Australian dentists from 1992 to 2018 - a pharmacoepidemiology study.
    Park JS; Kruger E; Tennant M
    Int Dent J; 2020 Aug; 70(4):254-258. PubMed ID: 32170731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012.
    Harris C; Daniels B; Ward RL; Pearson SA
    Public Health Res Pract; 2017 Dec; 27(5):. PubMed ID: 31044212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future.
    Pearson SA; Pratt N; de Oliveira Costa J; Zoega H; Laba TL; Etherton-Beer C; Sanfilippo FM; Morgan A; Kalisch Ellett L; Bruno C; Kelty E; IJzerman M; Preen DB; Vajdic CM; Henry D
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of privacy-preserving record linkage to examine the dispensing of pharmaceutical benefits scheme medicines to pregnant women in Western Australia.
    Kelty E; Hansen M; Randall S; Gration D; Baynam G; Preen DB
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5845. PubMed ID: 38825961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data.
    Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL
    Med J Aust; 2023 Jul; 219(2):63-69. PubMed ID: 37230472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
    Gobarani RK; Ilomäki J; Wood S; Abramson MJ; Bonevski B; George J
    Addiction; 2022 Oct; 117(10):2683-2694. PubMed ID: 35603915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the dispensing patterns of antipsychotics in Australia from 2006 to 2018 - A pharmacoepidemiology study.
    Claassen JN; Park JS
    Res Social Adm Pharm; 2021 Jun; 17(6):1159-1165. PubMed ID: 32928657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers.
    Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA
    BMC Res Notes; 2015 Nov; 8():634. PubMed ID: 26526064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians.
    Pearson SA; Schaffer A
    BMJ Open; 2014 May; 4(5):e004099. PubMed ID: 24793244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
    Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
    Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.
    Robertson J; Walkom EJ; Henry DA
    Aust Health Rev; 2009 May; 33(2):192-9. PubMed ID: 19563308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Australian Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: challenges and approaches.
    Page E; Kemp-Casey A; Korda R; Banks E
    Public Health Res Pract; 2015 Sep; 25(4):e2541546. PubMed ID: 26536508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine utilisation in Australia: report from a new pharmacoepidemiological database.
    Mant A; Whicker SD; McManus P; Birkett DJ; Edmonds D; Dumbrell D
    Aust J Public Health; 1993 Dec; 17(4):345-9. PubMed ID: 7911332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressivity of out-of-pocket costs under Australia's universal health care system: A national linked data study.
    Law HD; Marasinghe D; Butler D; Welsh J; Lancsar E; Banks E; Biddle N; Korda R
    Health Policy; 2023 Jan; 127():44-50. PubMed ID: 36456400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.